Modulation of Class II MHC Antigens by Tgfbeta

Reimold, Andreas M.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
• Type: Clinical Investigator Award (CIA) (K08)
• Project #: 5K08AR001915-04
• Application #: 2077472
• Study Section: Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
• Project Start: 1993-08-15
• Project End: 1998-06-30
• Budget Start: 1996-07-01
• Budget End: 1997-06-30
• Support Year: 4
• Fiscal Year: 1996

Institution

• Name: Harvard University
• Department: Biology
• Type: Schools of Public Health
• DUNS #: 082359691
• City: Boston
• State: MA
• Country: United States
• Zip Code: 02115

Publications

Montani, V; Shong, M; Taniguchi, S I et al. (1998) Regulation of major histocompatibility class II gene expression in FRTL-5 thyrocytes: opposite effects of interferon and methimazole. Endocrinology 139:290-302

Montani, V; Taniguchi, S I; Shong, M et al. (1998) Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein. Endocrinology 139:280-9